301685-23-4

Basic information

• Product Name: Hexanoic acid, 2-[[formyl(phenylmethoxy)amino]methyl]-, (2R)-
• CAS NO: 301685-23-4
• Molecular Formula: C15H21NO4
• Molecular Weight: 279.336
• Mol File: 301685-23-4.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Hexanoic acid, 2-[[formyl(phenylmethoxy)amino]methyl]-, (2R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Hexanoic acid, 2-[[formyl(phenylmethoxy)amino]methyl]-, (2R)-(301685-23-4)
• EPA Substance Registry System: Hexanoic acid, 2-[[formyl(phenylmethoxy)amino]methyl]-, (2R)-(301685-23-4)

Safety Data

• Hazardous Substances Data: 301685-23-4(Hazardous Substances Data)

Upstream product

• 478912-43-5 4-benzyl-3-[2-(benzyloxyamino-methyl)-hexanoyl]-oxazolidin-2-one 
• 478912-40-2 (4S)-3-(2-methylene-1-oxohexyl)-4-(phenylmethyl)-2-oxazolidinone 
• 143965-32-6 (4S)-3-hexanoyl-4-(phenylmethyl)-1,3-oxazolidin-2-one 
• 72773-04-7 N-formylbenzotriazole 
• 234768-83-3 (2R)-2-({[(phenylmethyl)oxy]amino}methyl)hexanoic acid 
• 29601-98-7 N-benzylhydroxylamine hydrochloride 
• 668485-39-0 (4S)-3-[(2R)-2-(hydroxymethyl)hexanoyl]-4-(phenylmethyl)-1,3-oxazolidin-2-one 
• 142-61-0 Hexanoyl chloride 
• 2985-32-2 butylmalonic acid monoethyl ester 
• 58243-89-3 (±)-2-butyl-3-hydroxypropionic acid 
• 2612-26-2 2-butylpropane-1,3-diol 
• 676127-84-7 (3R)-3-butyl-1-[(phenylmethyl)oxy]-2-azetidinone 
• 676127-83-6 C₁₅H₂₃NO₅S 
• 676127-81-4 (2R)-2-(hydroxymethyl)-N-[(phenylmethyl)oxy]hexanamide 

Downstream Products

• 609366-92-9 (R)-2-[(Benzyloxy-formyl-amino)-methyl]-hexanoic acid ((S)-1-dimethylcarbamoyl-ethyl)-amide 
• 609367-17-1 (R)-2-[(Benzyloxy-formyl-amino)-methyl]-hexanoic acid [(S)-1-dimethylcarbamoyl-2-(4-hydroxy-phenyl)-ethyl]-amide 
• 609367-19-3 (S)-1-{(R)-2-[(Benzyloxy-formyl-amino)-methyl]-hexanoyl}-pyrrolidine-2-carboxylic acid dimethylamide 
• 1281973-31-6 C₂₀H₂₉N₃O₅ 
• 1101196-58-0 C₁₉H₂₇N₃O₅ 
• 1101196-52-4 C₂₀H₂₉N₃O₅ 
• 1101196-53-5 C₁₉H₂₆FN₃O₅ 
• 1101196-54-6 C₂₃H₃₃FN₄O₆ 
• 1101196-55-7 C₂₃H₃₃ClN₄O₆ 
• 1281973-26-9 C₂₅H₃₁N₃O₅ 
• 1101196-43-3 C₁₈H₂₅N₃O₅ 
• 1101196-81-9 C₂₆H₃₃N₃O₅ 
• 1101196-83-1 C₂₅H₃₀FN₃O₅ 
• 1281973-27-0 C₂₅H₂₉F₂N₃O₅ 

Relevant articles and documents

Peptide deformylase inhibitors

The present invention relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods directed to bacterial infections and inhibition of bacterial peptide deformylase (PDF) activity.

Synthesis and in vitro antibacterial activity of oxazolidine LBM-415 analogs as peptide deformylase inhibitors

The drug resistant bacteria pose a severe threat to human health. The increasing resistance of those pathogens to traditional antibacterial therapy renders the identification of new antibacterial agents with novel antibacterial mechanisms an urgent need.

PDF INHIBITORS

The invention relates to novel compounds that are inhibitors of peptidyl deformylase (PDF). The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and uses of the compounds are also disclosed.